clarithromycin has been researched along with digoxin in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (22.22) | 18.2507 |
2000's | 22 (48.89) | 29.6817 |
2010's | 12 (26.67) | 24.3611 |
2020's | 1 (2.22) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Esaki, T; Kawashima, H; Komura, H; Kuroda, M; Mizuguchi, K; Natsume-Kitatani, Y; Ohashi, R; Watanabe, R | 1 |
Etingin, OR; Midoneck, SR | 1 |
Baltch, AL; Ford, A; Smith, LC; Smith, RP | 1 |
Brown, BA; Griffith, DE; Wallace, RJ; Warden, R | 1 |
Alt, M; Arpin-Bott, MP; Guillemet, C; Imler, M | 1 |
Laberge, P; Martineau, P | 1 |
Hyman, J; Lichstein, E; Trivedi, S | 1 |
Guanci, R; Lilley, LL | 1 |
Clark, RF; Manoguerra, AS; Nordt, SP; Williams, SR | 1 |
Futami, T; Hashida, T; Inui, K; Ito, T; Nohara, R; Sasayama, S; Wakasugi, H; Yano, I | 1 |
Ito, S; Juurlink, DN | 1 |
Rashkow, A; Xu, H | 1 |
Higuchi, S; Ieiri, I; Irie, S; Kimura, M; Kurata, Y; Morita, T; Ohdo, S; Ohtani, H; Otsubo, K; Sawada, Y; Urae, A | 1 |
Horga, JF; Pérez-Mateo, M; Reus, S; Tello, A; Torrús, D; Zapater, P | 1 |
Kotegawa, T; Kuranari, M; Matsuki, S; Morimoto, T; Nakano, S; Otani, Y; Tsutsumi, K | 1 |
Katayama, Y; Kodama, M; Matsumoto, K; Miyatake, K; Tanaka, H; Ueno, K; Yoneda, K | 1 |
Juurlink, DN; Kopp, A; Laupacis, A; Mamdani, M; Redelmeier, DA | 1 |
Karlstadt, RG; Walker, K | 1 |
Burhenne, J; Göggelmann, C; Haefeli, WE; Ludwig, J; Mikus, G; Rengelshausen, J; Riedel, KD; Walter-Sack, I; Weiss, J | 1 |
Arnheim, K | 1 |
Azam, S; Dhakam, S; Kiran, N | 1 |
García-García, JA; Merchante, N; Mira, JA; Vergara-López, S | 1 |
Fujita, M; Furukubo, T; Hasegawa, I; Hirata, S; Izumi, S; Ohtani, H; Ota, M; Sawada, Y; Yamakawa, T | 1 |
Barone, GW; Breen, P; Carrier, J; Cheboyina, S; Gurley, BJ; Hubbard, MA; Song, PF; Tong, Y; Williams, DK; Yates, CR | 1 |
Asahi, S; Ebihara, T; Higuchi, T; Ikemoto, K; Katoh, M; Niwa, S; Takeuchi, T; Yokoi, T; Yoshitomi, S | 1 |
Barone, GW; Breen, P; Cheboyina, S; Gurley, BJ; Hubbard, MA; Stuart, LB; Swain, A; Tong, Y; Williams, DK; Yates, CR | 1 |
Ito, S; Murakami, H; Nasu, R; Ohtani, H; Sawada, Y; Tsujimoto, M | 1 |
Barone, G; Battu, SK; Gurley, BJ; Swain, A; Williams, DK | 1 |
Gomes, T; Juurlink, DN; Mamdani, MM | 1 |
Chan, AL; Su, CY; Tsai, FH; Wang, MT | 1 |
Hu, ZY; Zhao, Y | 1 |
Gomes, T; Huang, A; Juurlink, DN; Macdonald, EM; Mamdani, MM; Quinn, KL | 1 |
Britz, H; Eissing, T; Frechen, S; Hanke, N; Lehr, T; Moj, D; Wendl, T | 1 |
Balzan, D; Callus, R; Delicata, L; Felice, T | 1 |
2 review(s) available for clarithromycin and digoxin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clarithromycin-induced digoxin toxicity: a case report and a review of the literature.
Topics: Aged; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Clarithromycin; Digoxin; Drug Interactions; Female; Humans; Time Factors | 2001 |
6 trial(s) available for clarithromycin and digoxin
Article | Year |
---|---|
A prospective study of the clarithromycin-digoxin interaction in elderly patients.
Topics: Aged; Aged, 80 and over; Bayes Theorem; Clarithromycin; Digoxin; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Patients; Prospective Studies | 2002 |
The effect of erythromycin and clarithromycin on the pharmacokinetics of intravenous digoxin in healthy volunteers.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Cardiotonic Agents; Clarithromycin; Digoxin; Drug Interactions; Erythromycin; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate | 2002 |
Effect of clarithromycin on steady-state digoxin concentrations.
Topics: Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B; Clarithromycin; Digoxin; Dose-Response Relationship, Drug; Drug Interactions; Female; Heart Failure; Humans; Male; Middle Aged | 2003 |
Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.
Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Clarithromycin; Creatinine; Cross-Over Studies; Digoxin; Double-Blind Method; Drug Interactions; Genes, MDR; Genotype; Humans; Infusions, Intravenous; Kidney; Male; Polymorphism, Genetic; Prospective Studies | 2003 |
Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans.
Topics: Administration, Oral; Adult; Area Under Curve; Cimicifuga; Clarithromycin; Dietary Supplements; Digoxin; Drug Administration Schedule; Female; Genes, MDR; Half-Life; Haplotypes; Herb-Drug Interactions; Humans; Male; Plant Preparations; Rifampin; Silybum marianum | 2006 |
Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans.
Topics: Adult; Cardiotonic Agents; Clarithromycin; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Digoxin; Drug Interactions; Female; Herb-Drug Interactions; Humans; Hydrastis; Kava; Male; Rifampin | 2007 |
37 other study(ies) available for clarithromycin and digoxin
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Development of an
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Cell Line; Computer Simulation; Endothelial Cells; Gene Knockout Techniques; Humans; Organic Chemicals; Rats, Transgenic | 2021 |
Clarithromycin-related toxic effects of digoxin.
Topics: Aged; Aged, 80 and over; Atrial Premature Complexes; Bronchitis; Clarithromycin; Digoxin; Drug Interactions; Female; Humans | 1995 |
Clarithromycin-induced digoxin toxicity in a patient with AIDS.
Topics: Aged; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Digoxin; Drug Interactions; Drug Therapy, Combination; Humans; Male | 1995 |
Clarithromycin-associated digoxin toxicity in the elderly.
Topics: Age Factors; Aged; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Atrial Fibrillation; Clarithromycin; Digoxin; Drug Interactions; Drug Therapy, Combination; Echocardiography; Ethambutol; Humans; Male; Mycobacterium avium-intracellulare Infection; Rifabutin | 1997 |
[Clarithromycin-digoxin: an unrecognized interaction in some patients].
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Clarithromycin; Digoxin; Drug Interactions; Humans; Male | 1997 |
Clarithromycin-induced digoxin intoxication.
Topics: Aged; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Blood Pressure; Bronchitis; Cardiomyopathies; Clarithromycin; Digoxin; Drug Interactions; Heart Rate; Humans; Kidney Failure, Chronic; Male | 1997 |
Clarithromycin and digoxin toxicity.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Digoxin; Drug Interactions; Drug Therapy, Combination; Female; Humans | 1998 |
A dangerous combination.
Topics: Aged; Anti-Bacterial Agents; Cardiotonic Agents; Clarithromycin; Digoxin; Diuretics; Drug Interactions; Furosemide; Heart Diseases; Humans; Male; Medication Errors; Memory | 1998 |
Clarithromycin induced digoxin toxicity.
Topics: Adult; Anorexia; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Clarithromycin; Digoxin; Drug Interactions; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Male; Vomiting | 1998 |
Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein.
Topics: Anti-Arrhythmia Agents; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Digoxin; Drug Interactions; Drug Therapy, Combination; Humans; Male; Metabolic Clearance Rate; Middle Aged | 1998 |
Comment: clarithromycin-digoxin interaction.
Topics: Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cardiotonic Agents; Clarithromycin; Digoxin; Drug Interactions; Humans | 1999 |
Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.
Topics: Administration, Oral; Adult; Alleles; Anti-Bacterial Agents; Area Under Curve; Asian People; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cardiotonic Agents; Clarithromycin; Cytochrome P-450 Enzyme System; Digoxin; Drug Administration Schedule; Drug Interactions; Enzyme Inhibitors; Genes, MDR; Genotype; Humans; Injections, Intravenous; Japan; Male; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Reference Values | 2002 |
Drug-drug interactions among elderly patients hospitalized for drug toxicity.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Asthmatic Agents; Anti-Infective Agents; Antihypertensive Agents; Case-Control Studies; Clarithromycin; Contraindications; Digoxin; Diuretics; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Glyburide; Hospitalization; Humans; Hyperkalemia; Hypoglycemia; Male; Ontario; Trimethoprim, Sulfamethoxazole Drug Combination | 2003 |
Update on prescribing information for pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Digoxin; Drug Interactions; Esophagitis; Humans; Nifedipine; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides | 2003 |
[Digitalis -- poisoning, myopathy, ergotism.... When antibiotic and associated therapy become dangerous mixture].
Topics: Acetylation; Analgesics, Non-Narcotic; Antacids; Anti-Bacterial Agents; Clarithromycin; Cytochrome P-450 Enzyme System; Digitalis Glycosides; Digoxin; Drug Interactions; Ergotamine; Ergotism; Female; Humans; Hypolipidemic Agents; Ketolides; Macrolides; Middle Aged; Migraine Disorders; Muscular Diseases; Risk Factors; Sinusitis; Vasoconstrictor Agents | 2003 |
Clarithromycin induced digoxin toxicity: case report and review.
Topics: Anti-Bacterial Agents; Anticoagulants; Atrial Fibrillation; Clarithromycin; Digoxin; Drug Interactions; Drug Therapy, Combination; Female; Humans; Middle Aged; Pneumonia, Bacterial; Warfarin | 2004 |
[Digoxin toxicity secondary to inhibition of digoxin intestinal metabolism in a patient receiving clarithromycin].
Topics: Aged; Anti-Bacterial Agents; Cardiotonic Agents; Clarithromycin; Digoxin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Intestinal Mucosa; Treatment Outcome | 2004 |
Interactions between clarithromycin and digoxin in patients with end-stage renal disease.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cardiotonic Agents; Clarithromycin; Digoxin; Drug Interactions; Female; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Renal Replacement Therapy | 2005 |
Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Clarithromycin; Digoxin; Dogs; Dose-Response Relationship, Drug; Haplorhini; Humans; Kinetics; LLC-PK1 Cells; Mice; Pharmaceutical Preparations; Rats; RNA, Messenger; Swine; Transfection; Verapamil; Vinblastine | 2006 |
Effect of macrolide antibiotics on uptake of digoxin into rat liver.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Biological Transport; Blood Flow Velocity; Cardiotonic Agents; Clarithromycin; Digoxin; Dose-Response Relationship, Drug; Drug Interactions; Erythromycin; Hepatocytes; Josamycin; Liver; Macrolides; Male; Permeability; Rats; Rats, Sprague-Dawley; Roxithromycin; Tissue Distribution | 2007 |
Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Dietary Supplements; Digoxin; Echinacea; Flavonoids; Ginkgo biloba; Herb-Drug Interactions; Hypericum; Rifampin | 2008 |
Macrolide-induced digoxin toxicity: a population-based study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azithromycin; Cardiotonic Agents; Case-Control Studies; Clarithromycin; Comorbidity; Digoxin; Drug Interactions; Erythromycin; Female; Humans; Macrolides; Male; Polypharmacy | 2009 |
Risk of digoxin intoxication caused by clarithromycin-digoxin interactions in heart failure patients: a population-based study.
Topics: Aged; Anti-Bacterial Agents; Cardiotonic Agents; Case-Control Studies; Clarithromycin; Cohort Studies; Digoxin; Dose-Response Relationship, Drug; Drug Interactions; Female; Heart Failure; Hospitalization; Humans; Male; Retrospective Studies | 2009 |
Physiologically based pharmacokinetic modelling and in vivo [I]/K(i) accurately predict P-glycoprotein-mediated drug-drug interactions with dabigatran etexilate.
Topics: Amiodarone; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; beta-Alanine; Clarithromycin; Dabigatran; Digoxin; Dronedarone; Drug Interactions; Humans; Models, Biological; Pyridines; Quinidine; Verapamil | 2014 |
Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Atrial Fibrillation; Azithromycin; Cardiotonic Agents; Case-Control Studies; Cefuroxime; Clarithromycin; Death, Sudden; Digoxin; Drug Interactions; Erythromycin; Female; Heart Failure; Humans; Macrolides; Male; Ontario; Risk Factors | 2017 |
PBPK Models for CYP3A4 and P-gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and Digoxin.
Topics: Alfentanil; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Cytochrome P-450 CYP3A; Digoxin; Drug Interactions; Humans; Itraconazole; Midazolam; Models, Biological; Rifampin | 2018 |
Digoxin toxicity precipitated by Helicobacter pylori eradication therapy.
Topics: Acute Kidney Injury; Aged, 80 and over; Amoxicillin; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Atrial Fibrillation; Bradycardia; Bundle-Branch Block; Clarithromycin; Digoxin; Drug Interactions; Electrocardiography; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hyperkalemia; Immunoglobulin Fab Fragments; Omeprazole; Tachycardia, Ventricular | 2019 |